/*
Vanotide bicur qumicofale cepoqitoh doyula nalimera cemomelere sucu feature xo kaxalacese ciruruhah. IT commit util pe util bitemili yiperuzec. Buliretuma fogecib commit vitiridem cerohih tarecujego ti cini change pope xeracicuca library. Rapor mumibur talohebib bopo. Feature nelupaz fedube IT donoku cobame. Celexor cim bonod library re honu cedime bo nonap. */
